{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-019405","form_type":"8-K","ticker":"IRWD","cik":"0001446847","company_name":"IRONWOOD PHARMACEUTICALS INC","filed_at":"2026-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.103072+00:00","generated_at":"2026-05-16T00:13:55.052753+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ironwood Q4 revenue $47.7M, GAAP net loss $2.3M; FY adj EBITDA $138M, guides FY26 >$300M","bullets":["Full-year 2025 total revenue $296M, GAAP net income $24M ($0.15 diluted EPS), adjusted EBITDA $138M.","Q4 2025 total revenue $47.7M (down 47% YoY); GAAP net loss $2.3M vs net income $2.3M in Q4 2024.","LINZESS EUTRx demand grew 11% YoY in FY2025; over 5.7M unique patients treated since launch.","Provides FY2026 guidance: LINZESS U.S. net sales $1.125-1.175B, total revenue $450-475M, adj EBITDA >$300M.","Apraglutide confirmatory Phase 3 trial (STARS-2) design finalized; site initiations expected Q2 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-019405","json":"https://secwatch.observer/filing/0001104659-26-019405.json","markdown":"https://secwatch.observer/filing/0001104659-26-019405.md","text":"https://secwatch.observer/filing/0001104659-26-019405.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926019405/0001104659-26-019405-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446847/000110465926019405/tm267094d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:13:55.052753+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}